• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺激素与心血管系统。

Thyroid hormone and the cardiovascular system.

机构信息

Department of Biological Sciences and Geology, Queensborough Community College, Bayside, NY 11364, USA.

出版信息

Med Clin North Am. 2012 Mar;96(2):257-68. doi: 10.1016/j.mcna.2012.01.006. Epub 2012 Feb 14.

DOI:10.1016/j.mcna.2012.01.006
PMID:22443974
Abstract

Thyroid hormone has profound effects on the heart and cardiovascular system. This article describes the cellular mechanisms by which thyroid hormone acts at the level of the cardiac myocyte and the vascular smooth muscle cell to alter phenotype and physiology. Because it is well established that thyroid hormone, specifically T(3), acts on almost every cell and organ in the body, studies on the regulation of thyroid hormone transport into cardiac and vascular tissue have added clinical significance. The characteristic changes in cardiovascular hemodynamics and metabolism that accompany thyroid disease states can then be best understood at the cellular level.

摘要

甲状腺激素对心脏和心血管系统有深远的影响。本文描述了甲状腺激素在心肌细胞和血管平滑肌细胞水平上发挥作用的细胞机制,从而改变表型和生理学。由于已经确定甲状腺激素,特别是 T3,作用于体内几乎每个细胞和器官,因此对甲状腺激素向心脏和血管组织转运的调节的研究增加了临床意义。伴随甲状腺疾病状态的心血管血液动力学和代谢的特征变化可以在细胞水平上得到最好的理解。

相似文献

1
Thyroid hormone and the cardiovascular system.甲状腺激素与心血管系统。
Med Clin North Am. 2012 Mar;96(2):257-68. doi: 10.1016/j.mcna.2012.01.006. Epub 2012 Feb 14.
2
Thyroid hormone and the cardiovascular system.甲状腺激素与心血管系统。
Minerva Endocrinol. 2004 Sep;29(3):139-50.
3
[Thyroid hormone and the cardiovascular system].[甲状腺激素与心血管系统]
Nihon Rinsho. 2006 Dec;64(12):2330-8.
4
[Cardiovascular effects of thyroid hormones].[甲状腺激素对心血管系统的影响]
Z Kardiol. 1996;85 Suppl 6:219-31.
5
Thyroid disease and the cardiovascular system.甲状腺疾病与心血管系统。
Endocrinol Metab Clin North Am. 2014 Jun;43(2):517-28. doi: 10.1016/j.ecl.2014.02.005.
6
Thyroid disease and the heart.甲状腺疾病与心脏
Circulation. 2007 Oct 9;116(15):1725-35. doi: 10.1161/CIRCULATIONAHA.106.678326.
7
Thyroid hormone and atherosclerosis.甲状腺激素与动脉粥样硬化。
Vascul Pharmacol. 2010 Mar-Apr;52(3-4):151-6. doi: 10.1016/j.vph.2009.09.004. Epub 2009 Oct 4.
8
Thyroid hormone and the cardiovascular system.甲状腺激素与心血管系统。
N Engl J Med. 2001 Feb 15;344(7):501-9. doi: 10.1056/NEJM200102153440707.
9
The crosstalk between thyroid hormones and the Renin-Angiotensin System.甲状腺激素与肾素-血管紧张素系统的相互作用。
Vascul Pharmacol. 2010 Mar-Apr;52(3-4):166-70. doi: 10.1016/j.vph.2009.10.009. Epub 2009 Oct 24.
10
[Thyroid hormone and the cardiovascular system].[甲状腺激素与心血管系统]
Dtsch Med Wochenschr. 2005 Sep 30;130(39):2215-9. doi: 10.1055/s-2005-916367.

引用本文的文献

1
Cardiovascular Findings and Effects of Caffeine on Experimental Hypothyroidism.心血管方面的发现以及咖啡因对实验性甲状腺功能减退的影响。
Endocr Metab Immune Disord Drug Targets. 2025 Jan 9. doi: 10.2174/0118715303315657240819114052.
2
Impaired sensitivity to thyroid hormones is associated with all-cause and cause-specific mortality among chronic kidney disease patients: results from National Health and Nutrition Examination Survey (NHANES) 2007-2012.甲状腺激素敏感性受损与慢性肾脏病患者的全因死亡率和特定病因死亡率相关:来自2007 - 2012年美国国家健康与营养检查调查(NHANES)的结果。
Ren Fail. 2024 Dec;46(2):2433178. doi: 10.1080/0886022X.2024.2433178. Epub 2024 Dec 17.
3
Association between FT3 Levels and Exercise-Induced Cardiac Remodeling in Elite Athletes.
精英运动员游离三碘甲状腺原氨酸水平与运动诱导的心脏重塑之间的关联
Biomedicines. 2024 Jul 10;12(7):1530. doi: 10.3390/biomedicines12071530.
4
Impact of thyroid hormone perturbations in adult mice: brain weight and blood vessel changes, gene expression variation, and neurobehavioral outcomes.甲状腺激素扰动对成年小鼠的影响:脑重和血管变化、基因表达变化以及神经行为结果。
Neurobiol Aging. 2023 Aug;128:74-84. doi: 10.1016/j.neurobiolaging.2023.04.012. Epub 2023 Apr 29.
5
Electrocardiographic biomarker based on machine learning for detecting overt hyperthyroidism.基于机器学习的心电图生物标志物用于检测显性甲状腺功能亢进症。
Eur Heart J Digit Health. 2022 Apr 20;3(2):255-264. doi: 10.1093/ehjdh/ztac013. eCollection 2022 Jun.
6
Emerging Biomarkers for Predicting Clinical Outcomes in Patients with Heart Disease.预测心脏病患者临床结局的新兴生物标志物
Life (Basel). 2023 Jan 13;13(1):230. doi: 10.3390/life13010230.
7
Myxedema heart disease and non-comatose presentation of myxedema: A case report.黏液性水肿性心脏病与黏液性水肿的非昏迷表现:一例报告。
SAGE Open Med Case Rep. 2022 Oct 8;10:2050313X221130227. doi: 10.1177/2050313X221130227. eCollection 2022.
8
Genome-wide association study of hyperthyroidism based on electronic medical record from Taiwan.基于台湾电子病历的甲状腺功能亢进症全基因组关联研究。
Front Med (Lausanne). 2022 Jul 27;9:830621. doi: 10.3389/fmed.2022.830621. eCollection 2022.
9
Artificial Intelligence in Cardiology-A Narrative Review of Current Status.心脏病学中的人工智能——现状的叙述性综述
J Clin Med. 2022 Jul 5;11(13):3910. doi: 10.3390/jcm11133910.
10
Development of Thyroid Hormones and Synthetic Thyromimetics in Non-Alcoholic Fatty Liver Disease.甲状腺激素与合成甲状腺刺激素在非酒精性脂肪性肝病中的作用。
Int J Mol Sci. 2022 Jan 20;23(3):1102. doi: 10.3390/ijms23031102.